Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare TechnologiesGEHC -0.75%75 Equity-to-Asset is 0.30 as of Jun. 2026, which is 11% above its 10-year median of 0.27. GuruFocus rates GEHC with a GF Score™ of 75/100 and a GF Value™ of $84.22 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 851 Medical Devices & Instruments companies, GE HealthCare Technologies ranks worse than 84.25% on this metric.
GE HealthCare Technologies (NAS:GEHC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
GE HealthCare Technologies Equity-to-Asset Related Terms
GE HealthCare Technologies Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GEHC vs DXCM, STE, ZBH: Equity-to-Asset Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Equity-to-Asset falls into.
GE HealthCare Technologies Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
GE HealthCare Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (GEHC) has a Equity-to-Asset of 0.30 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on GE HealthCare Technologies and its competitors. This is 11% above median its historical median of 0.27. Over the past decade, GE HealthCare Technologies' Equity-to-Asset has ranged from 0.21 to 0.65. According to the industry distribution chart, GE HealthCare Technologies ranks #717 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 84.3%.
Is GE HealthCare Technologies' Equity-to-Asset too high?
GE HealthCare Technologies' current Equity-to-Asset of 0.30 is 11% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 0.65. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. GE HealthCare Technologies' value of 0.30 is 53.1% below this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #717 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Equity-to-Asset compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #717 out of 851 companies for Equity-to-Asset. This places GE HealthCare Technologies in the lower half of its industry. The industry median Equity-to-Asset is 0.64. GE HealthCare Technologies' value of 0.30 is 53.1% below this benchmark. Historically, GE HealthCare Technologies' own Equity-to-Asset has ranged from 0.21 to 0.65 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 0.64, GE HealthCare Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current Equity-to-Asset of 0.30 is 53.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current Equity-to-Asset is 0.30, which is 11% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $84.22, compared to a current price of $74.06 — trading 12.1% below its estimated fair value. The current Equity-to-Asset is 0.30, which is 11% above median its 10-year median of 0.27 and 53.1% below the Medical Devices & Instruments industry median of 0.64. GE HealthCare Technologies' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For GE HealthCare Technologies (GEHC), the current Equity-to-Asset is 0.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of $74.06 is trading 12.1% below its estimated GF Value™ of $84.22.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for GEHC:
Equity-to-Asset: 0.30 (11% above median its 10-year median of 0.27)
GF Value™: $84.22 vs. price of $74.06 (12.1% below fair value)
Industry Position: 53.1% below the Medical Devices & Instruments median (#717 of 851)
No single metric tells the full story. See the GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
75GF Score
Get the complete analysis for GEHC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GEHC has been successfully added to your 
